Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

2.

Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.

Chen L, Yang B.

Int J Gynecol Pathol. 2008 Jul;27(3):326-32. doi: 10.1097/PGP.0b013e31815ea7f5.

PMID:
18580309
3.
4.
5.

Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.

Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC.

Am J Surg Pathol. 2002 Mar;26(3):292-300.

PMID:
11859200
6.

Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.

Petrović D, Babić D, Forko JI, Martinac I.

Coll Antropol. 2010 Mar;34(1):93-7.

PMID:
20437637
7.

A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.

Lee CH, Turbin DA, Sung YC, Espinosa I, Montgomery K, van de Rijn M, Gilks CB.

Mod Pathol. 2009 Dec;22(12):1519-31. doi: 10.1038/modpathol.2009.122. Epub 2009 Sep 4.

8.
10.

Differentiation, proliferation and apoptosis levels in human leiomyoma and leiomyosarcoma.

Valenti MT, Azzarello G, Vinante O, Manconi R, Balducci E, Guidolin D, Chiavegato A, Sartore S.

J Cancer Res Clin Oncol. 1998;124(2):93-105.

PMID:
9654192
11.

[Analysis for predicting the prognostic factors of gastrointestinal tract leiomyosarcoma using MIB-1 and DNA flow cytometry].

Nishio T, Nakagomi H, Mutou S, Miyake T, Hagiwara J, Ashizawa I, Oyama T, Takano K, Tada Y.

Gan To Kagaku Ryoho. 1998 Apr;25 Suppl 3:475-80. Japanese.

PMID:
9589056
12.

The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.

Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.

Cancer. 1998 Jun 1;82(11):2262-9.

PMID:
9610708
14.

p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas.

O'Reilly PE, Raab SS, Niemann TH, Rodgers JR, Robinson RA.

Mod Pathol. 1997 Feb;10(2):91-7. Review.

PMID:
9127313
15.

Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).

Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K.

Acta Obstet Gynecol Scand. 2004 Nov;83(11):1085-8.

PMID:
15488127
16.

Prognostic value of ploidy and proliferation markers in renal cell carcinoma.

Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.

Cancer. 1996 Jan 1;77(1):164-71.

17.
18.

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.

Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S.

Gynecol Oncol. 2005 Oct;99(1):36-42.

PMID:
15992918
19.

Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.

Can B, Sökmensüer C.

Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccxliii-ccxlviii.

PMID:
15244191
20.

p53 protein overexpression in smooth muscle tumors of the uterus.

Niemann TH, Raab SS, Lenel JC, Rodgers JR, Robinson RA.

Hum Pathol. 1995 Apr;26(4):375-9.

PMID:
7705814

Supplemental Content

Support Center